Literature DB >> 27270280

In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.

Sarah L Bowler1, Caressa N Spychala1, Christi L McElheny1, Roberta T Mettus1, Yohei Doi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27270280      PMCID： PMC4958153          DOI： 10.1128/AAC.01124-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.

Authors:  N C Gordon; K Png; D W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

2.  Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

Authors:  Zubair A Qureshi; Lauren E Hittle; Jessica A O'Hara; Jesabel I Rivera; Alveena Syed; Ryan K Shields; Anthony W Pasculle; Robert K Ernst; Yohei Doi
Journal:  Clin Infect Dis       Date:  2015-01-28       Impact factor: 9.079

3.  Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.

Authors:  Lynette M Phee; Jonathan W Betts; Binutha Bharathan; David W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

4.  Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.

Authors:  Jessica A O'Hara; Lauretta A Ambe; Leila G Casella; Bethany M Townsend; Mark R Pelletier; Robert K Ernst; Robert M Q Shanks; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

Review 5.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132
  5 in total
  4 in total

Review 1.  In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.

Authors:  Stamatis Karakonstantis; Petros Ioannou; Diamantis D Kofteridis
Journal:  Infection       Date:  2022-01-04       Impact factor: 3.553

Review 2.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

Review 3.  Acinetobacter baumannii Resistance: A Real Challenge for Clinicians.

Authors:  Rosalino Vázquez-López; Sandra Georgina Solano-Gálvez; Juan José Juárez Vignon-Whaley; Jorge Andrés Abello Vaamonde; Luis Andrés Padró Alonzo; Andrés Rivera Reséndiz; Mauricio Muleiro Álvarez; Eunice Nabil Vega López; Giorgio Franyuti-Kelly; Diego Abelardo Álvarez-Hernández; Valentina Moncaleano Guzmán; Jorge Ernesto Juárez Bañuelos; José Marcos Felix; Juan Antonio González Barrios; Tomás Barrientos Fortes
Journal:  Antibiotics (Basel)       Date:  2020-04-23

Review 4.  Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?

Authors:  Aline Vidal Lacerda Gontijo; Sharlene Lopes Pereira; Herval de Lacerda Bonfante
Journal:  Curr Microbiol       Date:  2021-12-14       Impact factor: 2.188
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.